🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. eythrocytapheresis

    Atrium Therapeutics

    Pre Operative Autologous Donation

    phase 3 other completed

    1 trial

  2. gemcitabine

    NORTHWEST BIOTHERAPEUTICS INC

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  3. gemcitabine and cisplatin (Induction chemotherapy)

    Sun Yat-sen University

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  4. gemcitabine and cisplatin (Induction chemotherapy)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  5. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 gene therapy active

    1 trial

  6. giroctocogene fitelparvovec, fidanacogene elaparvovec

    Pfizer Australia Pty Ltd

    hemophilia A, severe to moderately severe hemophilia B (FIX:C ≤ 2%)

    phase 3 small molecule active

    1 trial

  7. golidocitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 3 small molecule active

    1 trial

  8. induced moderate hypothermia

    Hospital Authority, Hong Kong

    Traumatic Brain Injury

    phase 3 other terminated

    1 trial

  9. infigratinib 0.128 mg/kg/day

    BridgeBio Oncology Therapeutics

    Hypochondroplasia

    phase 3 small molecule active

    1 trial

  10. intensity-modulated radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 other active

    1 trial

  11. lefamulin

    Nabriva Therapeutics Ireland DAC

    Community Acquired Pneumonia

    phase 3 small molecule completed

    1 trial

  12. lomustine

    United Therapeutics Europe Ltd

    Brain and Central Nervous System Tumors

    phase 3 small molecule completed

    1 trial

  13. lorundrostat

    Mineralys Therapeutics

    Hypertension

    phase 3 small molecule active

    1 trial

  14. low titer whole blood

    United Therapeutics Europe Ltd

    Hemorrhagic Shock

    phase 3 mab completed

    1 trial

  15. masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib

    AB Science

    Amyotrophic Lateral Sclerosis

    phase 3 small molecule active

    1 trial

  16. mesalazine (Asacol®)

    Cardiff Oncology

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  17. metformin hydrochloride

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  18. metronomic adjuvant chemotherapy with capecitabine

    Chongqing Claruvis Pharmaceutical Co.,

    Nasopharyngeal Cancinoma (NPC)

    phase 3 small molecule active

    1 trial

  19. mifepristone

    CORCEPT THERAPEUTICS INC

    Major Depressive Disorder

    phase 3 small molecule completed

    5 trials

  20. mifepristone

    CORCEPT THERAPEUTICS INC

    Psychotic Depression

    phase 3 small molecule terminated

    1 trial

  21. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Disease

    phase 3 small molecule terminated

    2 trials

  22. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Syndrome

    phase 3 small molecule completed

    2 trials

  23. migalastat HCl 150 mg

    AMICUS THERAPEUTICS PTY LTD

    Fabry Disease

    phase 3 small molecule completed

    1 trial

  24. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources